Literature DB >> 8205448

Abnormal transient internal sphincter relaxation in idiopathic pruritus ani: physiological evidence from ambulatory monitoring.

R Farouk1, G S Duthie, A Pryde, D C Bartolo.   

Abstract

Patients with idiopathic pruritus ani have an abnormal rectoanal inhibitory reflex and a lower threshold for internal sphincter relaxation during the saline continence test. This led to the hypothesis that these patients may exhibit abnormalities of the transient internal anal sphincter relaxation reflex. To study this, 23 men of median age 41 (range 27-64) years with idiopathic pruritus ani and 16 male controls of median age 39 (range 26-68) years were assessed using computerized ambulatory anorectal electromyography and manometry. Resting anal pressure, maximum anal squeeze pressure, internal sphincter electromyogram frequency, the number of internal sphincter relaxations and pudendal nerve terminal motor latency were similar for the two groups. The rise in rectal pressure during internal sphincter relaxation was higher in patients with pruritus than in controls (median (range) 29 (18-60) versus 18 (11-37) cmH2O, P < 0.01). Furthermore, the fall in anal pressure was greater in patients with pruritus than in controls (median (range) 39 (15-52) versus 29 (21-43) cmH2O, P < 0.01). The duration of internal sphincter relaxation was prolonged in patients compared with controls (median (range) 29 (18-55) versus 8 (5-12) s, P < 0.001). Fourteen patients reported staining of underclothes and 17 complained of perianal itch within 1 h of these episodes of abnormal internal sphincter relaxation. Pruritus ani may result from occult faecal leakage as a result of abnormal transient internal sphincter relaxation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8205448     DOI: 10.1002/bjs.1800810442

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Long-term results of single intradermal 1 % methylene blue injection for intractable idiopathic pruritus ani: a prospective study.

Authors:  N E Samalavicius; T Poskus; R K Gupta; R Lunevicius
Journal:  Tech Coloproctol       Date:  2012-06-06       Impact factor: 3.781

2.  1% hydrocortisone ointment is an effective treatment of pruritus ani: a pilot randomized controlled crossover trial.

Authors:  R Al-Ghnaniem; K Short; A Pullen; L C Fuller; J A Rennie; A J M Leather
Journal:  Int J Colorectal Dis       Date:  2007-05-30       Impact factor: 2.571

Review 3.  Pruritus Ani.

Authors:  Parswa Ansari
Journal:  Clin Colon Rectal Surg       Date:  2016-03

Review 4.  What every gastroenterologist needs to know about common anorectal disorders.

Authors:  Moonkyung Cho Schubert; Subbaramiah Sridhar; Robert R Schade; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

5.  Topical capsaicin--a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study.

Authors:  J Lysy; M Sistiery-Ittah; Y Israelit; A Shmueli; N Strauss-Liviatan; V Mindrul; D Keret; E Goldin
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

Review 6.  Pruritus ani.

Authors:  S Siddiqi; V Vijay; M Ward; R Mahendran; S Warren
Journal:  Ann R Coll Surg Engl       Date:  2008-09       Impact factor: 1.891

Review 7.  Idiopathic Pruritus Ani and Acute Perianal Dermatitis.

Authors:  Adrián E Ortega; Xavier Delgadillo
Journal:  Clin Colon Rectal Surg       Date:  2019-08-22

8.  Comparative evaluation of the effect of sustained inflation and rapid inflation/deflation of the intrarectal balloon upon rectoanal inhibitory reflex parameters in asymptomatic subjects.

Authors:  F J R Monteiro; F S P Regadas; S M Murad-Regadas; L V Rodrigues; V M Leal
Journal:  Tech Coloproctol       Date:  2007-12-03       Impact factor: 3.781

9.  Long-term follow-up of intradermal injection of methylene blue for intractable, idiopathic pruritus ani.

Authors:  J H Kim; D H Kim; Y P Lee
Journal:  Tech Coloproctol       Date:  2019-02-07       Impact factor: 3.781

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.